This article contains information sourced from:
Proinflammatory cytokines alter the expression of immune-related molecules on the surface of thyroid cells, such as the upregulation of major histocompatibility complex (MHC) molecules, making thyroid cells more likely to be recognized by the immune system and attacked by immune cells (Yan et al., 2024)
Gastrointestinal adverse events (affecting 79.6% in the cagrilintidesemaglutide group and 39.9% in the placebo group), including nausea, vomiting, diarrhea, constipation, or abdominal pain, were mainly transient and mild-to-moderate in severity
Weuve J, Barnes LL, Mendes de Leon CF, et al
Baumgarten, K